Clinical Trial Update: Gemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With Irinotecan [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial evaluates a second-line combination of gemcitabine, capecitabine, and oxaliplatin for advanced colorectal cancer previously treated with iri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Yonsei University | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: UNKNOWN